注意力缺陷多动障碍药物处方增加与现实结局随时间的变化
结果显示,ADHD药物使用与自残、意外伤害、交通事故和犯罪风险降低相关,但意外伤害、交通事故和犯罪的风险降低幅度随处方率上升而减弱。
要点
- ADHD药物使用与自残、意外伤害、交通事故和犯罪风险降低持续相关。
- 意外伤害、交通事故和犯罪的风险降低关联随处方率上升而减弱。
- 年龄和性别分布变化不能完全解释意外伤害和交通事故的减弱趋势。
核心结论
- ADHD药物仍与多种严重现实结局风险降低相关,但关联强度随处方率上升而减弱。
- 需定期评估不同患者群体的药物使用情况。
主要发现
- ADHD药物使用与自残风险降低相关,IRR范围为0.77(95%CI 0.73-0.81)至0.85(95%CI 0.82-0.88)。
- ADHD药物使用与意外伤害风险降低相关,IRR范围为0.87(95%CI 0.84-0.89)至0.93(95%CI 0.91-0.95)。
- ADHD药物使用与交通事故风险降低相关,IRR范围为0.71(95%CI 0.67-0.77)至0.87(95%CI 0.83-0.91)。
- ADHD药物使用与犯罪风险降低相关,IRR范围为0.73(95%CI 0.71-0.75)至0.84(95%CI 0.82-0.85)。
- 意外伤害、交通事故和犯罪的风险降低关联随时间减弱,趋势P值均<.01。
关键数值与推荐
- ADHD药物患病率从0.6%增至2.8%,对应2006-2010、2011-2015、2016-2020三个时期。
- 自残、意外伤害、交通事故和犯罪的风险降低在不同年龄、性别和时间段内一致。
临床怎么用
- 临床应继续关注ADHD药物对自残、意外伤害、交通事故和犯罪等现实结局的保护作用。
- 随着处方率上升,需定期评估药物在不同患者群体中的获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The prescription of attention-deficit/hyperactivity disorder (ADHD) medications has risen substantially in many countries over the last 20 years. However, whether the real-world benefits of ADHD medications change with increased prescription rates within a society remains unknown. OBJECTIVE: To examine whether the associations between ADHD medications and real-world outcomes (self-harm, unintentional injury, traffic crashes, and crime) change as prescription rates rise. DESIGN, SETTING, AND PARTICIPANTS: This study used a self-controlled case series design. It was a population-based study using Swedish National Registers that included individuals who used ADHD medications in Sweden between 2006 and 2020. Data were analyzed from October 2023 to November 2024. EXPOSURE: ADHD medication use. MAIN OUTCOMES AND MEASURES: Rates of self-harm, unintentional injury, traffic crashes, and crime during medicated vs nonmedicated periods. The associations between ADHD medication and these real-world outcomes were examined across 3 time periods, 2006 to 2010, 2011 to 2015, and 2016 to 2020, during which ADHD medication prevalence increased from 0.6% to 2.8%. RESULTS: There were 247 420 individuals identified (99 361 females [40.2%] and 148 059 males [59.8%]) aged 4 to 64 years in Sweden who used ADHD medications between 2006 and 2020. ADHD medication was consistently associated with lower risks for self-harm (incidence rate ratio [IRR] ranged from 0.77; 95% CI, 0.73-0.81 to 0.85; 95% CI, 0.82-0.88), unintentional injury (IRR ranged from 0.87; 95% CI, 0.84-0.89 to 0.93, 95% CI, 0.91-0.95), traffic crashes (IRR ranged from 0.71; 95% CI, 0.67-0.77 to 0.87; 95% CI, 0.83-0.91), and crime (IRR ranged from 0.73; 95% CI, 0.71-0.75 to 0.84; 95% CI, 0.82-0.85) across different age groups, sexes, and over time. However, the associations between ADHD medication use and lower risks of unintentional injury (P value for trend < .01), traffic crashes (P value for trend < .01), and crime (P value for trend < .01) appear to weaken over time as prescription rates increased. Changes in age and sex distribution of individuals receiving ADHD medication did not fully explain the weakening trend for unintentional injury and traffic crashes. CONCLUSIONS AND RELEVANCE: In this study, ADHD medication remained associated with reduced risks of several serious real-world outcomes. However, the magnitude of these associations appears to have decreased alongside rising prescription rates over time. Thus, it is important to regularly evaluate medication use in different patient populations.
引用
- Li L, Coghill D, Sjölander A, et al. Increased Prescribing of Attention-Deficit/Hyperactivity Disorder Medication and Real-World Outcomes Over Time. JAMA Psychiatry. 2025. PMID: 40560574. doi:10.1001/jamapsychiatry.2025.1281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。